Literature DB >> 17984937

In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender.

Wojciech Zgliczynski1, Magdalena Kochman, Waldemar Misiorowski, Piotr Zdunowski.   

Abstract

OBJECTIVES: The aim of our study was to evaluate bone metabolism and bone mineral density (BMD), and to indicate the main determinants of these parameters in a large group of patients with active acromegaly.
METHODS: A group of 121 active acromegalics, aged 23-80 years, from a single endocrinological center was studied. Serum GH, IGF-I, LH, FSH, PRL, estradiol/testosterone, osteocalcin (OC), type I collagen carboxyterminal telopeptide (ICTP) as well as BMD by DXA at spine L2-L4, femoral neck, Ward's triangle and trochanter were measured.
RESULTS: Serum OC and ICTP concentrations were elevated (mean+/-SEM: 31.7+/-2.2 microg/L, p<0.001; 7.3+/-0.5 microg/L, p<0.001, respectively), and positively correlated with each other, as well as with IGF-I. BMD (Z-scores) was increased at L2-L4, femoral neck and trochanter (0.35+/-0.15, p=0.016; 0.60+/-0.11, p<0.001 and 0.59+/-0.13, p<0.001; respectively). The main determinants of Z-scores and ICTP were gonadal status and gender, while of OC was IGF-I. Eugonadal acromegalics had higher than normal serum OC and ICTP, as well as Z-scores at all measured sites. Hypogonadal patients (2/3 of the population) had significantly higher serum ICTP concentrations and lower BMD at all sites, when compared to eugonadal acromegalics. Thirty five percent of hypogonadal subjects had T-score<-1. Men had significantly higher serum ICTP and lower Z-scores than women.
CONCLUSIONS: (i) In active acromegaly, enhanced IGF-I-dependent bone turnover and increased BMD is observed. (ii) In hypogonadal acromegalics, high bone resorption decreases BMD and may lead to osteoporosis. (iii) There is a smaller increase in bone resorption and greater increase in BMD in women with acromegaly than in men.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17984937

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  10 in total

1.  Entropy and uniformity as additional parameters to optimize the effectiveness of bone CT in the evaluation of acromegalic patients.

Authors:  Olga de Castro Dytz; Pedro de Azevedo Berger; Márcio Garrison Dytz; Bernardo Alves Barbosa; Armindo Jreige Júnior; Neysa Aparecida Tinoco Reggatieri; Arthur Disegna; Wagner Diniz de Paula; Luiz Augusto Casulari; Luciana Ansaneli Naves
Journal:  Endocrine       Date:  2020-06-10       Impact factor: 3.633

2.  Exon 3-deleted growth hormone receptor isoform is not related to worse bone mineral density or microarchitecture or to increased fracture risk in acromegaly.

Authors:  J Pontes; M Madeira; C H A Lima; L L Ogino; F de Paula Paranhos Neto; L M C de Mendonça; M L F Farias; L Kasuki; M R Gadelha
Journal:  J Endocrinol Invest       Date:  2019-08-07       Impact factor: 4.256

3.  Effects of GH-IGF-I excess and gonadal status on bone mineral density and body composition in patients with acromegaly.

Authors:  M Madeira; L V Neto; G A B de Lima; R O Moreira; L M C de Mendonça; M R Gadelha; M L F Farias
Journal:  Osteoporos Int       Date:  2010-03-20       Impact factor: 4.507

Review 4.  Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis.

Authors:  Cláudia Ribeiro de Moura; Sara Campos Lopes; Ana Margarida Monteiro
Journal:  Pituitary       Date:  2022-07-22       Impact factor: 3.599

5.  Growth hormone stimulates the collagen synthesis in human tendon and skeletal muscle without affecting myofibrillar protein synthesis.

Authors:  Simon Doessing; Katja M Heinemeier; Lars Holm; Abigail L Mackey; Peter Schjerling; Michael Rennie; Kenneth Smith; Søren Reitelseder; Anne-Marie Kappelgaard; Michael Højby Rasmussen; Allan Flyvbjerg; Michael Kjaer
Journal:  J Physiol       Date:  2009-11-23       Impact factor: 5.182

Review 6.  Growth hormone, insulin-like growth factors, and the skeleton.

Authors:  Andrea Giustina; Gherardo Mazziotti; Ernesto Canalis
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

7.  Trabecular bone score as a skeletal fragility index in acromegaly patients.

Authors:  A R Hong; J H Kim; S W Kim; S Y Kim; C S Shin
Journal:  Osteoporos Int       Date:  2015-10-07       Impact factor: 4.507

Review 8.  Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis.

Authors:  Vittorio Locatelli; Vittorio E Bianchi
Journal:  Int J Endocrinol       Date:  2014-07-23       Impact factor: 3.257

9.  Osteoarticular changes in acromegaly.

Authors:  Zdenko Killinger; Martin Kužma; Lenka Sterančáková; Juraj Payer
Journal:  Int J Endocrinol       Date:  2012-09-12       Impact factor: 3.257

10.  Preoperative and Postoperative Bone Mineral Density Change and Risk Factor Analysis in Patients with a GH-Secreting Pituitary Adenoma.

Authors:  Li'nan Qin; Xiaopeng Guo; Lu Gao; Zihao Wang; Chenzhe Feng; Kan Deng; Wei Lian; Bing Xing
Journal:  Int J Endocrinol       Date:  2019-11-03       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.